Enhancing Adverse Event Identification and Management in Early-Phase Oncology Clinical Trials: The Emerging Role of

Sheena Charles1

  • 1From The University of Texas MD Anderson Cancer Center, Houston, Texas.

Abstract

Insights

Advanced practice providers (APPs) are crucial for managing adverse events (AEs) in early-phase oncology clinical trials (EPOCT). Their involvement improves AE reporting and patient outcomes, though standardized training and comparative studies are needed.

Area of Science:

  • Oncology
  • Clinical Trials
  • Patient Safety

Background:

  • Adverse events (AEs) pose significant risks in early-phase oncology clinical trials (EPOCT) due to experimental therapies.
  • Effective AE identification and management are vital for patient safety, trial success, and scientific advancement.
  • Advanced practice providers (APPs) are integral to AE detection and management, bridging clinical care and research, yet their full impact in EPOCT is not fully understood.

Purpose of the Study:

  • To review the literature on AE identification, reporting, and management within EPOCT.
  • To explore the specific role and impact of APPs in managing AEs during EPOCT.
  • To emphasize the influence of APPs on patient outcomes, clinical trial efficiency, and oncology research.

Main Methods:

  • Systematic literature search conducted from 2020 to 2025 across multiple databases.
  • Inclusion criteria focused on studies related to AE management in EPOCT, patient-reported outcomes (PROs), and APP roles.
  • Exclusion criteria targeted studies not relevant to oncology, AE management, or healthcare providers.

Main Results:

  • AE reporting shows variability; electronic PRO tools enhance data capture timeliness and accuracy.
  • APPs significantly contribute to outpatient AE management, reducing emergency visits and improving treatment adherence.
  • Challenges include underreporting with clinician tools, inconsistent APP training, and limited data comparing APP-led to physician-led AE management.

Conclusions:

  • APPs are essential for improving AE reporting and optimizing clinical trial processes.
  • Future research should prioritize standardizing APP training programs.
  • Comparative studies evaluating the efficacy of APP-led AE management are recommended.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.8K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
839